FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2736952052> ?p ?o ?g. }

• W2736952052 endingPage "775" @default.
• W2736952052 startingPage "771" @default.
• W2736952052 abstract "Several intralesional therapeutic protocols have been proposed for the treatment of Peyronie's disease. Among all, hyaluronic acid (HA) and verapamil have been differently tested. We aimed to evaluate the efficacy of intralesional verapamil (ILVI) compared with intralesional HA in patients with early onset of Peyronie's disease (PD). This is a multi-centre prospective double-arm, randomized, double-blinded study comparing ILVI vs. intralesional HA after 12-weeks. Sexually active men, older than 18 years and affected by the acute phase of PD were eligible for this study. Patients have been double-blinded randomly divided into two groups (1 : 1 ratio): Group A received intralesional treatment with Verapamil (10 mg in 5 mL of normal saline water) weekly for 12 weeks, while group B received intralesional treatment with HA (0.8% highly purified sodium salt HA 16 mg/2 mL) weekly for 12 weeks. The primary efficacy outcome was the change from the baseline to the endpoint (12 weeks after therapy) for the penile curvature (degree). The secondary outcome was the change in the plaque size and in the International Index of erectile Function (IIEF-5) score. The difference between post- and pre-treatment plaque size was −1.36 mm (SD ± 1.27) for Group A and −1.80 mm (SD ± 2.47) for Group B (p-value = NS). IIEF-5 increased of 1.46 points (SD ± 2.18) in Group A and 1.78 (SD ± 2.48) in Group B (p-value ± NS). No difference in penile curvature was observed in Group A, while in Group B the penile curvature decreased of 4.60° (SD ± 5.63) from the baseline (p < 0.001) and vs. Group A. According to PGI-I results, we found significant difference as concerning patient global impression of improvement (PGI-I) (4.0 vs. 2.0; p < 0.05). This prospective, double-arm, randomized, double-blinded study comparing ILVI vs. HA as intralesional therapy showed greater efficacy of HA in terms of penile curvature and PGI-I." @default.
• W2736952052 created "2017-07-31" @default.
• W2736952052 creator A5017321899 @default.
• W2736952052 creator A5023670384 @default.
• W2736952052 creator A5025279590 @default.
• W2736952052 creator A5026426412 @default.
• W2736952052 creator A5033097058 @default.
• W2736952052 creator A5038120868 @default.
• W2736952052 creator A5042409536 @default.
• W2736952052 creator A5042911985 @default.
• W2736952052 creator A5046567234 @default.
• W2736952052 creator A5048032405 @default.
• W2736952052 creator A5051501450 @default.
• W2736952052 creator A5064417182 @default.
• W2736952052 creator A5075010803 @default.
• W2736952052 creator A5081270850 @default.
• W2736952052 creator A5084594446 @default.
• W2736952052 creator A5086523083 @default.
• W2736952052 creator A5090059102 @default.
• W2736952052 creator A5091669231 @default.
• W2736952052 date "2017-07-01" @default.
• W2736952052 modified "2023-10-16" @default.
• W2736952052 title "Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study" @default.
• W2736952052 cites W1133061708 @default.
• W2736952052 cites W1495606016 @default.
• W2736952052 cites W1502525967 @default.
• W2736952052 cites W1568034267 @default.
• W2736952052 cites W1991846705 @default.
• W2736952052 cites W1999109601 @default.
• W2736952052 cites W2022673893 @default.
• W2736952052 cites W2032500729 @default.
• W2736952052 cites W2034779792 @default.
• W2736952052 cites W2042877041 @default.
• W2736952052 cites W2043417932 @default.
• W2736952052 cites W2047862729 @default.
• W2736952052 cites W2056646391 @default.
• W2736952052 cites W2073816821 @default.
• W2736952052 cites W2076046741 @default.
• W2736952052 cites W2091455054 @default.
• W2736952052 cites W2159833782 @default.
• W2736952052 cites W2396932462 @default.
• W2736952052 doi "https://doi.org/10.1111/andr.12368" @default.
• W2736952052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28718527" @default.
• W2736952052 hasPublicationYear "2017" @default.
• W2736952052 type Work @default.
• W2736952052 sameAs 2736952052 @default.
• W2736952052 citedByCount "38" @default.
• W2736952052 countsByYear W27369520522018 @default.
• W2736952052 countsByYear W27369520522019 @default.
• W2736952052 countsByYear W27369520522020 @default.
• W2736952052 countsByYear W27369520522021 @default.
• W2736952052 countsByYear W27369520522022 @default.
• W2736952052 countsByYear W27369520522023 @default.
• W2736952052 crossrefType "journal-article" @default.
• W2736952052 hasAuthorship W2736952052A5017321899 @default.
• W2736952052 hasAuthorship W2736952052A5023670384 @default.
• W2736952052 hasAuthorship W2736952052A5025279590 @default.
• W2736952052 hasAuthorship W2736952052A5026426412 @default.
• W2736952052 hasAuthorship W2736952052A5033097058 @default.
• W2736952052 hasAuthorship W2736952052A5038120868 @default.
• W2736952052 hasAuthorship W2736952052A5042409536 @default.
• W2736952052 hasAuthorship W2736952052A5042911985 @default.
• W2736952052 hasAuthorship W2736952052A5046567234 @default.
• W2736952052 hasAuthorship W2736952052A5048032405 @default.
• W2736952052 hasAuthorship W2736952052A5051501450 @default.
• W2736952052 hasAuthorship W2736952052A5064417182 @default.
• W2736952052 hasAuthorship W2736952052A5075010803 @default.
• W2736952052 hasAuthorship W2736952052A5081270850 @default.
• W2736952052 hasAuthorship W2736952052A5084594446 @default.
• W2736952052 hasAuthorship W2736952052A5086523083 @default.
• W2736952052 hasAuthorship W2736952052A5090059102 @default.
• W2736952052 hasAuthorship W2736952052A5091669231 @default.
• W2736952052 hasBestOaLocation W27369520521 @default.
• W2736952052 hasConcept C105702510 @default.
• W2736952052 hasConcept C126322002 @default.
• W2736952052 hasConcept C126894567 @default.
• W2736952052 hasConcept C141071460 @default.
• W2736952052 hasConcept C168563851 @default.
• W2736952052 hasConcept C188816634 @default.
• W2736952052 hasConcept C203092338 @default.
• W2736952052 hasConcept C204243189 @default.
• W2736952052 hasConcept C2777022698 @default.
• W2736952052 hasConcept C2777397205 @default.
• W2736952052 hasConcept C2777529286 @default.
• W2736952052 hasConcept C2779145901 @default.
• W2736952052 hasConcept C2779929075 @default.
• W2736952052 hasConcept C519063684 @default.
• W2736952052 hasConcept C71924100 @default.
• W2736952052 hasConcept C90924648 @default.
• W2736952052 hasConceptScore W2736952052C105702510 @default.
• W2736952052 hasConceptScore W2736952052C126322002 @default.
• W2736952052 hasConceptScore W2736952052C126894567 @default.
• W2736952052 hasConceptScore W2736952052C141071460 @default.
• W2736952052 hasConceptScore W2736952052C168563851 @default.
• W2736952052 hasConceptScore W2736952052C188816634 @default.
• W2736952052 hasConceptScore W2736952052C203092338 @default.
• W2736952052 hasConceptScore W2736952052C204243189 @default.
• W2736952052 hasConceptScore W2736952052C2777022698 @default.

• next